L17: part 2 Flashcards

1
Q

What are NAD+ precursors?

A

 Co-enzyme, exists in all living cells
 Important for energy production
 Two forms: NAD+ (oxidized, accepts electrons) and NADH (Reduced, donates electrons).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Role of NAD in cardiac energy metabolism: essential coenzyme?

A

Glycolysis, beta-ox and TCA cycle all need NAD+.
NADH is especially needed in oxidative phosphorylation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ATP, calcium, NAD+, mito’s…. all is declined during ageing. shocking

A

ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Is there a way to supplement NAD+? With what?

A

Yes, with

  1. NAM (Nicotinamide)
  2. NA (Nicotic acid) Ken dit Plaatje uit je hoofd!!
  3. NR (Nicotinamide riboside)

These are all vit B3!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does supplementing nicotinamide work for improving heart?

A

 Nicotinamide (NAM) supplementation improves diastolic dysfunction and HFpEF by
1. increasing energy metabolism
2. decreasing acetylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is atrial fibrillation (AF)? Is it bad? Is it common?

A
  • rapid + irregular activation of the atria (400-600bpm)
  • progressive disease without curative therapy
  • most common arrythmea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In AF (atrial fibrillation), does the heart actually beat 400-600 times?

A

Not all waves can reach the ventricles. Therefore, they don’t beat as fast as 400-600 bpm. More like 2x higher (120-200).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Risk factors of AF?

A
  • Ageing
  • Obesity
  • Diabetes
  • Hypertension
  • Vulvar heart disease
  • ….
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Consequences of AF?

A
  • Stroke
  • Heart failure
  • Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AF classification?

A

Paroxysmal: <1 week
Persistent: >1 week
Long standing persistent: > 12 months
Permanent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do all AF treatments have in common?

A

target the symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the underlying cause for AF?

A

atrial remodeling.
This is the pathological changes of the atria

Reason for progressiveness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What three types of atrial remodeling are there?

A

Electrical: e.g. reduced calcium amplitude
Metabolic: e.g. mito dysf, NAD metabolism.
Structural: e.g. degration contractile proteins

First, within couple of days: electrical remodelling. Change in action potential.
Metabolic remodeling in the middle, structural remodeling happening later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Metabolic remodeling: how come?

A

AF: energy demand is higher, bc of high contraction rate, than the supply. Energy deficit.
Over time, this causes mitochondrial damage. = metabolic remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Major roles of NAD(H) in cellular physiology:

A
  1. As co-enzyme (energy production)
  2. As co-substrate (cellular signalling).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NAD+ declines with ageing. Shocker. But why?

A

due to increased consumption. Production of NAD+ does NOT change.

17
Q

Enzyme often involved in AF = PARP1 enzyme. explain.

A

More PAR = more activation of PARP1 enzyme = more NAD+ depletion

PARP1 is activated during DNA damage, over-activation =DNA depletion + cell death

18
Q

 In AF: significantly high PAR (indicating PARP activity), leading to much NAD+ depletion.

A

ok

19
Q

How to prevent loss of NAD+ in the cells? Two ways. Which one better?

A

 PARP inhibitor: prevents loss of NAD+ in the cells. Or, supply with NAD+

  • NAD+: vit B3 precursor is a natural product, safer.
  • Too much inhibition of PARP1 might not be good for other cells, other than the heart.
20
Q

Pipeline for developing new treatment for AF?

A

invitro cellular
in vitro drosophila
in vitro mammalian
human clinical trials